Hem › Crohns sjukdom
Kliniska studier för Crohns sjukdom som rekryterar i USA
93 studier för Crohns sjukdom rekryterar deltagare vid platser över hela USA.
Städer med flest studier
- New York City, NY35 studier
- Cleveland, OH19 studier
- St. Louis, MO19 studier
- Boston, MA19 studier
- Miami, FL19 studier
- Orlando, FL17 studier
- Houston, TX17 studier
- Atlanta, GA17 studier
- Tyler, TX16 studier
- San Diego, CA15 studier
- San Antonio, TX15 studier
- Los Angeles, CA15 studier
- Philadelphia, PA13 studier
- Colorado Springs, CO13 studier
- Durham, NC12 studier
- Providence, RI12 studier
- Tacoma, WA11 studier
- Pittsburgh, PA11 studier
- Cincinnati, OH11 studier
- Seattle, WA11 studier
- Baltimore, MD10 studier
- Washington, DC10 studier
- Indianapolis, IN10 studier
- Dallas, TX10 studier
- Lubbock, TX10 studier
- Tampa, FL10 studier
- Ann Arbor, MI9 studier
- Chicago, IL9 studier
- Louisville, KY9 studier
- Evanston, IL9 studier
- Lewisville, TX9 studier
- Rochester, MN8 studier
- Parma, OH8 studier
- New Haven, CT8 studier
- Columbus, OH8 studier
- Charlotte, NC8 studier
- Independence, MO8 studier
- Milwaukee, WI7 studier
- Lafayette, LA7 studier
- Queens, NY7 studier
Efter delstat
- Alabama9 studier
- Arizona17 studier
- Arkansas3 studier
- Colorado18 studier
- Connecticut14 studier
- District of Columbia4 studier
- Florida27 studier
- Georgia22 studier
- Idaho4 studier
- Illinois18 studier
- Indiana13 studier
- Iowa8 studier
- Kalifornien37 studier
- Kansas11 studier
- Kentucky12 studier
- Louisiana11 studier
- Maryland15 studier
- Massachusetts27 studier
- Michigan20 studier
- Minnesota11 studier
- Mississippi3 studier
- Missouri21 studier
- Nevada8 studier
- New Hampshire3 studier
- New Jersey9 studier
- New York36 studier
- North Carolina20 studier
- Ohio30 studier
- Oklahoma8 studier
- Oregon4 studier
- Pennsylvania23 studier
- Rhode Island12 studier
- South Carolina11 studier
- South Dakota4 studier
- Tennessee10 studier
- Texas35 studier
- Utah8 studier
- Virginia15 studier
- Washington22 studier
- Wisconsin7 studier
Nyligen uppdaterade studier
Officiell studietext (engelska)
Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
RekryterarObservationsstudie
Ålder 18 till 85 · Alla kön · Uppdaterad 2 okt. 2026 · NCT07619547Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
RekryterarFas 3
Alla åldrar · Alla kön · Uppdaterad 2 okt. 2026 · NCT06651281A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
RekryterarFas 3
Ålder 16 till 80 · Alla kön · Uppdaterad 2 okt. 2026 · NCT06430801Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 2 okt. 2026 · NCT07697456Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance
RekryterarFriska volontärer välkomna
Ålder 18 till 75 · Alla kön · Uppdaterad 2 okt. 2026 · NCT07033208Investigating the Effect of the Non-nutritive Sweetener Sucralose in Inflammatory Bowel Disease
RekryterarFriska volontärer välkomna
Ålder 18 till 75 · Alla kön · Uppdaterad 1 okt. 2026 · NCT07852273A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
RekryterarFas 4
Ålder 18 till 80 · Alla kön · Uppdaterad 30 sep. 2026 · NCT06581328Non-nutritive Sweeteners in Inflammatory Bowel Disease
RekryterarFriska volontärer välkomna
Ålder 18 till 70 · Alla kön · Uppdaterad 25 sep. 2026 · NCT07769437A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
RekryterarFas 3
Ålder 2 till 17 · Alla kön · Uppdaterad 25 sep. 2026 · NCT05923073Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 25 sep. 2026 · NCT06548542A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07499232A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
RekryterarFas 2/3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07196722A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
RekryterarFas 3
Ålder 3 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06663332A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 25 sep. 2026 · NCT06233461Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
RekryterarFas 3
Ålder 18 till 70 · Alla kön · Uppdaterad 24 sep. 2026 · NCT06937099Tailored Anti-Inflammatory American Diet for Patients With Crohn's Disease
Rekryterar
Ålder 16 till 75 · Alla kön · Uppdaterad 24 sep. 2026 · NCT07671872Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2026 · NCT03816345An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
RekryterarFas 3
Ålder 16 till 80 · Alla kön · Uppdaterad 23 sep. 2026 · NCT07184931A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
RekryterarFas 3
Ålder 16 till 80 · Alla kön · Uppdaterad 23 sep. 2026 · NCT07184944A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
RekryterarFas 3
Ålder 2 till 17 · Alla kön · Uppdaterad 23 sep. 2026 · NCT05995353A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
RekryterarFas 2
Ålder 18 till 85 · Alla kön · Uppdaterad 22 sep. 2026 · NCT06226883A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
RekryterarFas 2
Ålder 18 till 80 · Alla kön · Uppdaterad 22 sep. 2026 · NCT07483073A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
RekryterarFas 3
Ålder 2 till 19 · Alla kön · Uppdaterad 22 sep. 2026 · NCT04844606A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
RekryterarFas 2
Ålder 18 till 80 · Alla kön · Uppdaterad 22 sep. 2026 · NCT07483099A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
RekryterarFas 4
Ålder 18 till 70 · Alla kön · Uppdaterad 9 sep. 2026 · NCT06045754Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.